Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Westwind Partners was a prominent Canadian independent full-service investment bank that specialized in providing financial advisory and capital markets services. While not a biotechnology or life sciences company itself, the firm was known for its significant presence in the institutional brokerage and investment banking sectors, often covering high-growth industries including energy, mining, and technology. The company was founded in 2002 and quickly established a reputation for its research-driven approach and execution capabilities in the Canadian and international markets. In 2008, Westwind Partners was acquired by Thomas Weisel Partners Group, which was subsequently acquired by Stifel Financial Corp.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Westwind Partners.